In KRAS-driven lung cancer, CJL led to enhanced activity of heat shock factor 1 (HSF1),11 which has been shown to enhance tumorigenesis in a variety of cancers49 but has not been studied in MYC-driven lymphoma. The gene discussed is HSF1; the disease is lung cancer.